Amedisys Current Ratio 2010-2024 | AMED

Amedisys current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Amedisys Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $0.53B $0.49B 1.09
2023-12-31 $0.50B $0.47B 1.05
2023-09-30 $0.47B $0.47B 1.00
2023-06-30 $0.43B $0.46B 0.92
2023-03-31 $0.41B $0.35B 1.15
2022-12-31 $0.39B $0.36B 1.09
2022-09-30 $0.39B $0.37B 1.06
2022-06-30 $0.40B $0.43B 0.92
2022-03-31 $0.39B $0.38B 1.03
2021-12-31 $0.36B $0.37B 0.95
2021-09-30 $0.43B $0.45B 0.95
2021-06-30 $0.39B $0.45B 0.87
2021-03-31 $0.38B $0.46B 0.83
2020-12-31 $0.36B $0.46B 0.79
2020-09-30 $0.41B $0.44B 0.94
2020-06-30 $0.45B $0.44B 1.02
2020-03-31 $0.47B $0.32B 1.48
2019-12-31 $0.35B $0.33B 1.07
2019-09-30 $0.30B $0.32B 0.95
2019-06-30 $0.28B $0.31B 0.88
2019-03-31 $0.27B $0.30B 0.91
2018-12-31 $0.22B $0.22B 1.01
2018-09-30 $0.23B $0.22B 1.06
2018-06-30 $0.26B $0.21B 1.21
2018-03-31 $0.34B $0.21B 1.63
2017-12-31 $0.31B $0.22B 1.45
2017-09-30 $0.27B $0.20B 1.33
2017-06-30 $0.27B $0.23B 1.21
2017-03-31 $0.24B $0.18B 1.32
2016-12-31 $0.22B $0.18B 1.19
2016-09-30 $0.19B $0.18B 1.06
2016-06-30 $0.18B $0.19B 0.95
2016-03-31 $0.18B $0.20B 0.88
2015-12-31 $0.18B $0.18B 1.00
2015-09-30 $0.22B $0.17B 1.26
2015-06-30 $0.17B $0.18B 0.96
2015-03-31 $0.15B $0.16B 0.89
2014-12-31 $0.14B $0.16B 0.84
2014-09-30 $0.14B $0.19B 0.75
2014-06-30 $0.16B $0.20B 0.79
2014-03-31 $0.20B $0.33B 0.63
2013-12-31 $0.21B $0.31B 0.66
2013-09-30 $0.23B $0.33B 0.71
2013-06-30 $0.18B $0.19B 0.95
2013-03-31 $0.18B $0.20B 0.90
2012-12-31 $0.21B $0.21B 1.01
2012-09-30 $0.23B $0.23B 1.01
2012-06-30 $0.24B $0.25B 0.96
2012-03-31 $0.24B $0.25B 0.94
2011-12-31 $0.23B $0.22B 1.05
2011-09-30 $0.21B $0.21B 0.98
2011-06-30 $0.21B $0.22B 0.95
2011-03-31 $0.32B $0.23B 1.40
2010-12-31 $0.29B $0.22B 1.36
2010-09-30 $0.28B $0.22B 1.29
2010-06-30 $0.29B $0.24B 1.22
2010-03-31 $0.26B $0.24B 1.09
2009-12-31 $0.22B $0.23B 0.95
2009-09-30 $0.20B $0.23B 0.86
2009-06-30 $0.17B $0.22B 0.80
2009-03-31 $0.20B $0.20B 1.01
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.194B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.391B 11.73
Quest Diagnostics (DGX) United States $16.058B 16.47
DaVita (DVA) United States $12.497B 15.52
Encompass Health (EHC) United States $9.126B 23.36
Chemed (CHE) United States $8.190B 25.03
Elanco Animal Health (ELAN) United States $6.335B 16.44
Option Care Health (OPCH) United States $5.388B 20.40
RadNet (RDNT) United States $4.578B 95.34
Astrana Health (ASTH) United States $2.939B 39.76
Addus HomeCare (ADUS) United States $2.192B 28.36
LifeStance Health (LFST) United States $2.118B 0.00
U.S Physical Therapy (USPH) United States $1.462B 39.11
Pennant (PNTG) United States $0.878B 46.37
Aveanna Healthcare Holdings (AVAH) United States $0.818B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00